SlidesetHIVINTEREST 2016HIV Leadership and Financing Strategies for Countries in sub-Saharan Africa | Debrework Zewdie, PhDView Slideset
SlidesetHIVINTEREST 2016Progress in Hepatitis B and C in sub-Saharan Africa | Magloire Biwole Sida, MDView Slideset
SlidesetHIVINTEREST 2016(Abstract) Outcomes of second-line therapy in HIV positive adults attending for routine care at Yaoundé Central Hospital | A.O. Mafotsing FopoussiView Slideset
SlidesetHIVINTEREST 2016(Abstract) HIV-1 group O infection in Cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges | A.F. AghokengView Slideset
SlidesetHIVINTEREST 2016(Abstract) Immune reconstitution and skewed responses after ART initiation in HIV I infected Ugandans | K. Nganou MakamdopView Slideset
SlidesetHIVINTEREST 2016(Abstract) Evaluating plasmatic biomarkers as disease signatures for the point of care monitoring of HIV-1 and comorbidities in resource limited regions | G. NchindaView Slideset
SlidesetHIVINTEREST 2016(Abstract) The effect of antiretroviral naïve HIV-1 infection on the ability of autologous NK cells to produce IFNg unpon exposure to Plasmodium falciparum- infected Erythrocytes | C. Sake NganeView Slideset
SlidesetHIVHIV Clinical Forum 2015Skills improvement Session 2: Analyzing clinical datasets: Challenges and pitfalls - Amanda Mocroft, MD, PhDView Slideset
SlidesetHIVHIV Clinical Forum 2015Skills improvement Session 1: Designing clinical trials: Highlights and tips - Alessandro Cozzi-Lepri, PhDView Slideset
